Development of Criteria for Therapeutic Duplications of Psycho-Nervous System Drugs

정신신경용계 의약품의 치료군 중복처방 평가기준(안) 개발

  • Received : 2010.10.22
  • Accepted : 2011.05.04
  • Published : 2011.06.30

Abstract

Therapeutic duplication (TD) is frequently reported inappropriate drug use in healthcare settings in Korea. This study was aimed to develop TD criteria for psycho-nervous system drugs (KFDA classification 117 and 119). ATC classification was used to determine therapeutic and/or chemical similarities among the 93 ingredients reviewed. Clinical practice guidelines, textbooks and product labels were referenced for principles and evidences of possible drug combination usage. 16 groups that listed ingredients to be considered as TD were established and the criteria would be helpful to prevent TDs.

Keywords

References

  1. 보건복지가족부 : 의약품 처방.조제 지원시스템(DUR) 2단계 시범사업 시행 계획. 보건복지가족부 공고 제 2009-284호 (2009.4.23).
  2. 보건복지가족부 : 의약품처방조제지원시스템(DUR) 2단계 시범사업 지침 안내. 보건복지가족부건강보험심사평가원 (2009.4).
  3. 보건복지가족부 : 의약품처방조제지원시스템(DUR) 2단계 제주도 시범사업 운영 교재. 보건복지가족부건강보험심사평가원 (2009.10).
  4. Omnibus Budget Reconciliation Act 1990 (OBRA'90) : Available at http://faculty.ksu.edu.sa/hisham/Documents/ Pharmacy_Docs/omnibus.pdf. Accessed on August 4, (2010).
  5. 건강보험심사평가원 : 약제정보 - 처방.조제안전정보(DUR). Avaialbe at http://www.hira.or.kr/rfl_dur_freeboard_public.do? method=listFreeBoard&bbrd_no=36&pgmid=HIRAB0304020 00000. Accessed August 4 (2010).
  6. AdvancePCS : Health Improvement Report (2003).
  7. (주)퍼스트디스 : 의료급여 환자별 의약품 적정사용 실태조사 연구보고서 (2006. 4. 21).
  8. 신현택 : 중복치료 의약품에 대한 적정사용정보 개발. 식품의약품 안전청 연구보고서 (2009. 11).
  9. 대한약사회 : 의약품사용평가 (DUR) 학술정보자료집 (2004).
  10. Meredith, S., Feldman, P. H., Frey, D., Hall, K., Arnold, K., Brown, N. J. and Ray, W. A. : Possible medication errors in home healthcare patients. J. Am. Geriatr. Soc. 49, 719 (2001). https://doi.org/10.1046/j.1532-5415.2001.49147.x
  11. Azoulay, L., Zargarzadeh, A., Salahshouri, Z., Oraichi, D. and Berard, A. : Inappropriate medication prescribing in community-dwelling elderly people living in Iran. Eur. J. Clin. Pharmacol. 61, 913 (2005). https://doi.org/10.1007/s00228-005-0036-4
  12. 식품의약품안전청 : 의약품등 분류번호에 관한 규정. 식품의약품 안전청 예규 제 196호 (2009. 8. 24).
  13. WHO Collaborating Centre for Drug Statistics Methodology : About the ATC/DDD system. Available at http://www.whocc.no/ atcddd/. Accessed on August 3 (2010).
  14. 식품의약품안전청 : 의약품 등 정보. Available at http://ezdrug. kfda.go.kr/kfda2. Accessed August 4 (2010).
  15. Chen, J. J., Nelson, M. V. and Swope, D. M. : Pharmacotherapy - A Pathophysiologic Approach 7th ed. The McGraw-Hill Companies, Inc. p. 977 (2008).
  16. National Collaborating Centre for Chronic Conditions. Parkinson's disease. National clinical guideline for diagnosis and management in primary and secondary care. London (UK): Royal College of Physicians. p. 237 (2006). Available at http://guidance.nice.org.uk/CG35/NICEGuidance/pdf/English. Accessed on August (2009).
  17. Crismon, M. L., Argo, T. R. and Buckley, P. F. : Pharmacotherapy A Pathophysiologic Approach 7th ed. The McGraw-Hill Companies, Inc. p. 1099 (2008).
  18. National Collaborating Centre for Mental Health. Schizophrenia: core interventions in the treatment and management of schizophrenia in adults in primary and secondary care. London (UK): National Institute for Health and Clinical Excellence (NICE); p. 41 (2009). Available at http://guidance.nice.org.uk/ CG82/Guidance. Accessed on September (2009).
  19. National Collaborating Centre for Mental Health. Bipolar disorder: the management of bipolar disorder in adults, children, and adolescents, in primary and secondary care. Leicester (UK): British Psychological Society, Royal College of Psychiatrists. p. 592 (2006). Available at http://guidance.nice. org.uk/CG38/Guidance. Accessed on September (2009).
  20. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. 2nd ed. Arlington (VA): American Psychiatric Association. p. 114 (2004).
  21. Kirkwood, C. K. and Melton, S. T. : Pharmacotherapy - A Pathophysiologic Approach 7th ed. The McGraw-Hill Companies, Inc. p. 1161 (2008).
  22. National Institute for Health and Clinical Excellence (NICE). Clinical Guidelines for the Management of Anxiety; Management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care (2004). Available at http://guidance.nice.org.uk/CG22/Guidance/pdf/English. Accessed on October (2009).
  23. Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J. and Wittchen, H. U. : Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association For Psychopharmacology. J. Psychopharmacol. 19, 567 (2005). https://doi.org/10.1177/0269881105059253
  24. Expert Consensus Panel for Obsessive-Compulsive Disorder : Treatment of obsessive-compulsive disorder. J. Clin. Psychiatry. 58, 2 (1997).
  25. American Psychiatric Association. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Arlington (VA): American Psychiatric Association. p. 96 (2007).
  26. Teter, C. J., Kando, J. C., Wells, B. G. and Hayes, P. E. : Pharmacotherapy - A Pathophysiologic Approach 7th ed. The McGraw-Hill Companies, Inc. p. 1123 (2008).
  27. National Collaborating Centre for Mental Health. Depression. The treatment and management of depression in adults. London (UK): National Institute for Health and Clinical Excellence (NICE). p. 64. (2009). Available at http://guidance. nice.org.uk/CG90/Guidance/pdf/English. Accessed on August (2010).
  28. Slattum, W., Swerdlow, R. H. and Hill, A. M. : Pharmacotherapy - A Pathophysiologic Approach 7th ed. The McGraw-Hill Companies, Inc. p. 1051 (2008).
  29. National Collaborating Centre for Mental Health, Social Care Institute for Excellence (SCIE), National Institute for Health and Clinical Excellence (NICE). Dementia: supporting people with dementia and their carers in health and social care. London (UK): National Institute for Health and Clinical Excellence (NICE). p. 417 (2006). Available at http://guidance. nice.org.uk/CG42/Guidance/pdf/English. Accessed on September (2009).
  30. 하태현, 구민성, 양종철, 김원, 김세주, 권준수, 김찬형 : 한국형 강박장애 치료 알고리듬 2007(IV):공존질환이 동반된 경우. 대한정신약물학회지 18, 414 (2007).
  31. 법제처 종합법령정보센터 : 법률 제10324호. 약사법. 제 26조. Available at http://www.law.go.kr/main.html. Accessed on August 10 (2010).
  32. 법제처 종합법령정보센터 : 법률 제 10387호. 의료법. 제 18조. Available at http://www.law.go.kr/main.html. Accessed on August 10 (2010).